Antiretroviral combination prevents HIV transmission but dangerous for some infants
Although drug regimens such as the protease inhibitor lopinavir-ritonavir may have lowered the HIV
transmission rates in newborns to less than 1%, a study finds that postnatal treatment with the combination was
more likely to cause adrenal dysfunction in newborns when compared with a zidovudine-based treatment. Read about
the nuances of the study and the researchers? recommendations. (Source: Modern Medicine Contemporary Pediatrics)
TRIZIVIR (Abacavir Sulfate, Lamivudine, And Zidovudine) Tablet, Film Coated [ViiV Healthcare Company]
Updated Date: Apr 7, 2011 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))